News

ADS Diagnostic announced that the Board of Directors of the Company at its meeting held on 29 May 2026, inter alia, have recommended the final dividend of Rs 1.2 per equity Share (i.e. 12%) , subject to the approval of the shareholders.

Net profit of A D S Diagnostic rose 71.43% to Rs 0.12 crore in the quarter ended March 2026 as against Rs 0.07 crore during the previous quarter ended March 2025. Sales rose 19.76% to Rs 4.00 crore in the quarter ended March 2026 as against Rs 3.34 crore during the previous quarter ended March 2025.For the full year,net profit rose 32.10% to Rs 1.07 crore in the year ended March 2026 as against Rs 0.81 crore during the previous year ended March 2025. Sales rose 77.25% to Rs 28.36 crore in the year ended March 2026 as against Rs 16.00 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales4.003.34 20 28.3616.00 77 OPM %7.256.29 -7.489.63 - PBDT0.160.15 7 1.511.24 22 PBT0.180.12 50 1.451.09 33 NP0.120.07 71 1.070.81 32 Powered by Capital Market - Live News

ADS Diagnostic will hold a meeting of the Board of Directors of the Company on 29 May 2026.

ADS Diagnostic will hold a meeting of the Board of Directors of the Company on 13 February 2026.Powered by Capital Market - Live News

Net profit of A D S Diagnostic rose 29.79% to Rs 0.61 crore in the quarter ended September 2025 as against Rs 0.47 crore during the previous quarter ended September 2024. Sales rose 147.22% to Rs 14.66 crore in the quarter ended September 2025 as against Rs 5.93 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales14.665.93 147 OPM %7.0313.15 - PBDT0.850.66 29 PBT0.820.62 32 NP0.610.47 30 Powered by Capital Market - Live News